capillus hair loss

Capillus is Proud to Debut at the Medica 2017 World Forum for Medicine

Capillus is Proud to Debut at the Medica 2017 World Forum for Medicine

Capillus, LLC Capillus is making its inaugural appearance at the Medica 2017 World Forum for Medicine. Medica 2017 which is taking place this week in Dusseldorf, Germany runs from November 13th to November 16th, 2017.

Capillus is not only delighted to be a first-time exhibitor at Medica, but it is equally excited to showcase its complete line of laser therapy caps including the recently released CapillusRX™ which contains more lasers than any low-level laser therapy device in the market for home treatment of hair loss.

Its 312 diodes provide maximum simultaneous coverage of the scalp by any device for treatment of hereditary hair loss. It is available only through the company’s global physician network.

Medica is the world’s largest medical trade fair for medical technology, electro-medical equipment, laboratory equipment, diagnostics and pharmaceuticals. The fair is held annually and it is open to trade visitors only.

Capillus New Design of Laser Therapy Caps

Capillus’ Chief Executive Officer, Carlos Piña, along with Chief Operating Officer, Maria Piña, Director of International Sales, Fernando Bermudez, and Director of International Distribution, Lisa Weaver will be attending Medica 2017.

“Capillus’ goal, during Medica 2017, is to showcase our full-line of laser therapy caps as an effective method of treating pattern baldness in men and women,” said Carlos Piña, Capillus Chief Executive Officer, “we wish to broaden our reach and educate distributors in all fields of medicine on how our products can help prevent hair loss and promote hair regrowth.”

Capillus will be meeting with major distributors from around the world including Mexico, South Korea, Saudi Arabia, and the United Arab Emirates during the Medica 2017 World Forum for Medicine.

In addition to its CapillusRX™ available only through its physician network, Capillus currently offers three FDA-Cleared laser caps for direct sale via 1) Capillus82™, an economical and convenient device with 82 laser diodes, 2) Capillus202™, a powerful yet affordable device containing 202 laser diodes, as well as 3) CapillusPRO™, a professional-grade device with 272 laser diodes. Capillus laser therapy caps use Low Level Laser Therapy technology (LLLT), which is a non-invasive and chemical-free medical treatment for hair loss.

The Capillus laser therapy caps use a six-minute protocol which greatly reduces the time it takes to receive treatment. Capillus laser therapy caps are manufactured in the USA from foreign-source raw materials. The Capillus facility is ISO 13485 compliant, and it is located in Miami, Florida.

About Capillus, LLC 

Capillus, LLC offers prescription and over-the-counter hair regrowth products and medical devices for both men and women suffering from hair loss.

The Capillus premiere product lines include low-level laser therapy (LLLT) devices that are FDA-cleared and manufactured in the US under the highest-quality certification standard for the medical device industry (ISO13485). Capillus also offers additional non-prescription clinical hair products for hair and scalp health. Capillus products are available directly to the public for at-home use and also to their network of physicians for office use.

For more information visit


Capillus Laser Cap

Michigan Hair Surgeon Now Providing Capillus® Laser Cap to Hair Loss Patients

Michigan Hair Surgeon Now Providing Capillus® Laser Cap to Hair Loss Patients

A new, mobile low level laser therapy (LLLT) product has arrived at Accents Cosmetic Surgery to help men and women prevent the progression of hair loss.

Called the Capillus272 Pro™, this wearable laser therapy product is designed to increase the flow of blood and natural growth factors directly to hair follicles, helping patients who suffer with androgenetic alopecia develop a thicker and fuller head of hair.

“I highly recommend the Capillus272 to all of my patients who are in the market for a low-level laser light therapy device,” says Dr. Mark Berkowitz, founder of Accents Cosmetic Surgery. “It is simple to use, it has science behind it, and it’s something that I believe in and use myself.”


Capillus272 Pro™ is cleared by the FDA for the treatment of androgenetic alopecia, or hair loss, in men and women.

The laser cap has been shown to promote up to 51% increase in hair count, according to independently reviewed clinical studies available online at

Compared to other low level laser therapy options, Capillus272 Pro™ offers patients a high degree of discretion and convenience. The laser insert is placed beneath the cap of an ordinary hat or head covering, allowing patients to enjoy treatment without the worry of prying eyes. Capillus272 Pro™ is battery-operated and comes with a complimentary carrying case, allowing for consistent use around the house, at the office, and even on vacation.

“Compliance is very important for low level laser light therapy,” Dr. Berkowitz explains in a video interview. “If you aren’t going to use it, it’s never going to work. Well with a cap, it is so easy. I put it on, I drive to work with it 3 times a week or I watch TV with the cap on. If you use the Capillus®, it will work for you.”

In addition to low level laser therapy with Capillus272 Pro™, Dr. Berkowitz offers a variety of surgical and non-surgical hair restoration options for men and women who suffer with hair loss.

Dr. Berkowitz specializes in the NeoGraft hair transplant procedure, having performed hundreds of procedures totaling over 1.4 million grafts in the Michigan area.

For more information on hair restoration with Capillus272 Pro™, visit